Mouse models of insulin dependent diabetes: Low‐dose streptozocin‐induced diabetes and nonobese diabetic (NOD) mice
Tóm tắt
Từ khóa
Tài liệu tham khảo
Makino S, 1978, The spontaneously non‐obese‐diabetic mouse, Exp Anim, 27, 27
Tochino Y, 1979, A new type of non‐obese diabetic mouse accompanied with sudden onset and insulitis, Saishin Igaku, 34, 1183
Herr RR, 1959, Isolation and characterization of streptozotocin, Antibiot Ann, 23, 236
Rakieten N, 1963, Studies on the diabetogenic action of streptozotocin (NSC‐37917), Cancer Chemother Rep, 29, 91
Gaulton GN, 1985, Assessment of the diabetogenic drugs alloxan and streptozotocin as models for the study of immune defects in diabetic mice, Diabetologia, 28, 769, 10.1007/BF00265026
Nichols WK, 1981, Streptozotocin effects on T‐lymphocytes and bone marrow cells, Clin Exp Immunol, 46, 627
Nevalainen DE, 1977, The response of C3H mice to streptozotocin. I. Thymic depression and leukocyte toxicity, Am J Med Technol, 43, 417
Creutzfeldt W, 1969, Diabetes, 110
Rerup CC, 1970, Drugs producing diabetes through damage of the insulin secreting cells, Pharmacol Rev, 23, 485
Gunnarsson R, 1975, Inhibition of insulin biosynthesis by alloxan, streptozotocin, and n‐nitrosomethylurea, Mol Pharmacol, 111, 759
Yonemura Y, 1984, Amelioration of diabetes mellitus in partially depancreatized rats by poly (ADP‐ribose) synthetase inhibitors: evidence of islet B‐cell regeneration, Diabetes, 33, 401, 10.2337/diab.33.4.401
Papaccio G, 1986, Acetyl‐homocysteine‐thiolactone‐induced increase of superoxide dismutase counteracts the effect of subdiabetogenic doses of streptozotocin, Diabetes, 35, 470, 10.2337/diab.35.4.470
Asplund K, 1984, Partial protection against streptozotocin‐induced hyperglycaemia by superoxide dismutase linked to polyethylene glycol, Acta Endocrinol, 107, 390
Beppu H, 1987, Diabetogenic action of streptozotocin: Essential role of membrane permeability, Acta Endocrinol, 114, 90
Paik SG, 1982, Induction of insulin‐dependent diabetes by streptozotocin: Inhibition by estrogens and potentiation by androgens, Diabetes, 31, 724, 10.2337/diab.31.8.724
Hahn H‐J, 1981, Plasma glucose and pancreatic insulin content in the early phase of streptozotocin‐induced diabetes (preliminary results), Acta Biol Med Germ, 40, 83
Kuttler B, 1982, Diabetes mellitus in mice induced by multiple subdiabetogenic doses of streptozotocin: age and sex dependence, Acta Biol Med Germ, 41, 1199
Kiesel U, 1983, Genetic control of low‐dose streptozotocin‐induced autoimmune diabetes in mice, J Immunol, 130, 1719, 10.4049/jimmunol.130.4.1719
Weber C, 1983, Major histocompatibility complex, genetic background and streptozotocin diabetes, Surg Forum, 34, 365
LePHandLeiterEH:Genetic control of diabetes induction by multiple low doses of streptozotocin in two BALB/c sublines. The Jackson Laboratory Annual Reports1986:1–2.
Duhault J, 1979, T cell dependency of streptozotocin induced diabetes, IRCS Med Sci, 7, 154
Buschard K, 1978, Is the diabetogenic effect of streptozotocin in part thymus‐dependent?, Acta Pathol Microbiol Scand [C], 86, 23
Hahn HJ, 1983, The effect of irradiation on the development of low‐dose streptozotocin diabetes in mice, Diabete Metab, 9, 42
Kolb H, 1986, Immunotherapy of type I diabetes, Lancet, 7, 97
KolbH OschilewskiM OschilewskiU SchwabE Marx‐SohoMoume C GreulichB BurkartV ZielasekJ andKieselU:Analysis of 22 immunomodulatory substances for efficacy in low‐dose streptozotocin‐induced diabetes.Diabetes Res. in press.
Leiter EH, 1984, Intracisternal type A particles in murine pancreatic B cells: immunocytochemical demonstration of increased antigen (p73) in genetically diabetic mice, Am J Pathol, 114, 46
Like AA, 1978, Streptozotocin‐induced pancreatic insulitis in mice: morphologic and physiologic studies, Lab Invest, 38, 470
Buschard K, 1977, Passive transfer of streptozotocin induced diabetes mellitus with spleen cells: Studies of synogeneic and allogeneic transfer to normal and athymic nude mice, Acta Pathol Microbiol Scand [C], 85, 469
Buschard K, 1978, T‐lymphocytes transfer streptozotocin induced diabetes mellitus in mice, Acta Pathol Microbiol Scand [C], 86, 277
Kiesel U, 1981, Strain dependency of the transfer of experimental immune insulitis in mice, Clin Exp Immunol, 43, 430
BraunM ArataM D'AlesandriVG LopezO BorcaMV andBasabeJC:Lodging in the pancreas of lymphocytes from normal and diabetic mice. Sixth International Congress of Immunology Abstract No. 1.46.9. Toronto 1986.
GleichmannH KlinkhammerC andPopowaP:Studies on the mechanism(s) of immunologically mediated hyperglycemia in mice: T‐cell‐dependent popliteal lymph node reactions to streptozotocin (STZ). Immunology of Diabetes Abstract No. P4.7 Edmonton 1986.
Sandler S, 1981, Islet implantation into mice with pancreatic insulitis, Acta Pathol Microbiol Scand [A], 89, 107
Kolb H, 1984, Cell mediated immunity to islet cells: lessons from animal studies, Behring Inst Mitt, 75, 33
Kolb‐BachofenV KieselU SchunkD andKolbH:Low‐dose streptozotocin‐induced diabetes in mice: electron microscopy reveals islet cell lysis and “single cell insulitis” prior to diabetes onset. Submitted for publication.
Maruyama T, 1986, Increased antibody‐dependent cell‐mediated cytotoxicity of spleen lymphocytes from low‐dose streptozotocin‐induced diabetes in mice, J Jpn Diabetes Soc, 29, 425
KantwerkG CobboldS WaldmannH andKolbH:L3T4+and Lyt 2+‐cells are both involved in the generation of low‐dose streptozotocin diabetes.Clin Exp Immunol in press.
Orci L, 1967, Image ultrastructurale de pinocytose dans le cellule de Kupffer du foie de rat, J Microsc, 6, 413
Kolb H, 1985, Effect of cyclosporin A on low‐dose streptozotocin diabetes in mice, Diabetes Res, 2, 191
Iwakiri R, 1986, Enhancement of streptozotocin (STZ) induced diabetes by cyclosporin A (CYA) in mice, Diabetes, 35, 183A
Iwakiri R, The Immunology of Diabetes Mellitus
Laron Z, 1984, Enhancement of streptozotocin‐induced diabetes in C57B1/6J mice by cyclosporin A, Diabetes, 33, 24A
KieselU OschilewskiM TaniguchiM andKolbH:Immunomodulation of experimental diabetes by administration of antibodies to I‐A I‐E and I‐J determinants. Submitted for publication.
WeberC LaForetG PernisG WeberD PerryL andReemtsmaK:Increased severity of multiple low‐dose streptozotocin (MLD‐SZN) diabetes in mice given anti‐la antibodies. Immunology of Diabetes Abstract No. P3.14 Edmonton 1986.
Tabata T, 1986, Protection of thymosin fraction 5 against multiple low dose streptozotocin‐induced diabetes in mice, Diabetes, 35, 68A
Huang SW, 1982, Pertussis vaccine inhibits immune insulitis induced with streptozotocin, Clin Exp Immunol, 48, 375
Flechner I, 1984, Immunomodulation of streptozotocin‐induced diabetes in mice by a lipopolysaccharide, Diabetes Res, 1, 231
Naji A, 1982, Protection from multiple “low‐dose” streptozotocin‐induced diabetes by an interferon inducer, Surg Forum, 33, 221
Kolb H, 1986, Suppression of low‐dose streptozotocin‐induced diabetes by immunomodulatory lectins, Diabetes Res, 3, 183
Weber CJ, Prevention of multiple low‐dose streptozotocin in B10.BR mice by whole‐body ultraviolet irradiation, Transplant Proc, 18, 812
Makino S, 1985, Current Topics in Clinical and Experimental Aspects of Diabetes Mellitus, 25
Tarui S, 1986, Insulitis and Type I Diabetes–Lessons from the NOD Mouse
Uchida K, 1985, Altered bile acid metabolism in nonobese, spontaneously diabetic (NOD) mice, Diabetes, 34, 79, 10.2337/diab.34.1.79
Nishimura M, 1983, Spontaneous gastric erosions in NOD and KK‐A*y mice, Lab Anim Sci, 33, 577
Fushimi H, 1985, Abnormalities in plasma catecholamine response and tissue catecholamine accumulation in streptozotocin diabetic rat and spontaneously diabetic NOD mice: a possible role for diabetic autonomic neuropathy, Diabetes Res Clin Pract O, 183
Maegawa H, 1983, Insulin binding and glucose uptake in isolated soleus muscles in spontaneously non‐obese diabetic mice, Biomed Res, 4, 533, 10.2220/biomedres.4.533
Emoto M, 1985, Decreased amylase activity of the pancreas in NOD mice, J Jpn Diabetes Soc, 28, 623
Funakawa S, 1984, Rapid development of renal complications in non‐obese diabetic (NOD) mice, Biomed Res, 5, 291, 10.2220/biomedres.5.291
Azuma K, 1985, The influence of maternal hyperglycemia on the fetal pancreas in the NOD mouse, Tokyo Wom Med Coll, 55, 456
Tokiwa Y, 1985, Insulin receptors in pregnant nonobese diabetic (NOD) mice, Acta Obstet Gynaecol Jpn, 37, 2353
Kidokoro R, 1984, Lysosomal inclusions in the liver of the non‐obese diabetic mouse, J Clin Electron Microsc, 17, 832
YoshidaT NishimuraM AbeT andKyogokuN:The development of abnormalities in amino‐acid metabolism and the pattern of amino‐acid concentration in the blood of NOD mice. Annual Study Report of the Research Group for Animal Models of Incurable Diseases 1985.
YoshidaT NishimuraN AbeT andKyogokuN:Abnormalities of amino acid metabolism in NOD mice as an animal model of type I diabetes. Annual Study Report of the Research Group for Animal Models of Incurable Diseases 1981.
Emoto M, 1983, Suc (Ala)3 pNA hydrolyzing activities in nonobese diabetic (NOD) mice, Igaku No Ayumi, 127, 105
Makino S, 1986, Insulitis and Type I Diabetes–Lessons from the NOD Mouse, 23
ProchazkaM SerrezeDV ColemanDL andLeiterEH:Genes controlling diabetogenic susceptibility in NOD/ChpJ mice. Immunology of Diabetes Abstract No. P 2.15 Edmonton 1986.
Komeda K., 1986, Insulitis and Type I Diabetes–Lessons from the NOD Mouse, 11
Acha‐Orbea H, The Immunology of Diabetes Mellitus
IkegamiH HattoriM MakinoS andEisenbarthGS:Analysis of the immunogenetics of the NOD mouse utilizing multiple strain combinations: two recessive diabetogenic genes linked with H‐2 (chromosome 17) and Thy‐1 (chromosome 9). Immunology of Diabetes Abstract No. S7 Edmonton 1986.
NishimuraMandMiyamotoH:Immunopathological influence of Ay db ob and nu genes on NOD‐inbred background as murine models for human type‐I diabetes. Sixth International Congress of Immunology Abstract No. 1.46.11. Toronto 1986.
Harada M, 1986, Insulitis and Type I Diabetes–Lessons from the NOD Mouse, 143
Makino S, 1986, Absence of insulitis and overt diabetes in athymic nude mice with NOD genetic background, Exp Anim, 35, 495, 10.1538/expanim1978.35.4_495
Ogawa M, 1985, The inhibitory effect of neonatal thymectomy on the incidence of insulitis in non‐obese‐diabetic (NOD) mice, Biomed Res, 6, 103, 10.2220/biomedres.6.103
Mori Y, 1985, Prevention of diabetes in NOD mice by cyclosporin, J Jpn Diabetes Soc, 28, 1167
Kida K, 1985, Effect of cyclosporin on insulitis and ICAs in NOD mice, Diabetes Res Clin Pract O, S299
Harada M, 1986, Suppression of overt diabetes in NOD mice by anti‐thymocyte serum or anti Thy 1,2 antibody, Exp Anim, 35, 501, 10.1538/expanim1978.35.4_501
Amano K, 1986, Basic and clinical applications of monoclonal anti‐islet cell surface antibodies from non‐obese diabetic (NOD) mice, Diabetes, 35, 71A
TokiJ OhtsukiH YasumizuR GoodRA NakamuraT IdaT KuzuyaH ImuraH TochinoY HamashimaY andIkeharaS:Prevention of type I diabetes in NOD mice by allogeneic bone marrow transplantation. Sixth International Congress of Immunology Abstract No. 3.47.15 Toronto 1986.
YasumizuR GoodRA NakamuraT IwaiH SugiuraK TokiJ MakinoS TochinoY OhtsukiH andIkeharaS:Treatment of insulin‐dependent diabetes in mice by bone marrow and fetal pancreas transplantation. Sixth International Congress of Immunology Abstract No. 3.47.16 Toronto 1986.
Fujita H, 1984, Retrovirus‐like particles in pancreatic B‐cells of NOD (non‐obese diabetic) mice, Biomed Res, 5, 67, 10.2220/biomedres.5.67
YoshidaTO NishimuraM KoideY FujishimaY HoriT MasamotoT WuC andHaraguchiS:Gene modifications and autoimmune mechanisms in NOD mouse strain as a model of human type I diabetes. Sixth International Congress of Immunology Abstract No. 3.47.42 Toronto 1986.
Harada M, 1985, Immunological analysis of the pathogenic mechanism of diabetes in non‐obese diabetes‐prone mice: an obligatory role of T lymphocytes, Diabetes Res Clin Pract O, 573
Takei I, 1986, Insulitis and Type I Diabetes–Lessons from the NOD Mouse, 101
Suzuki M, 1984, Islet cell surface antibodies and complement‐dependent antibody‐mediated cytotoxicity in the NOD mouse, J Jpn Diabetes Soc, 27, 1095
KoikeT IshiiT TomiokaH andYoshidaS:Immunological study of nonobese diabetic (NOD) mouse. Sixth International Congress of Immunology Abstract No. 3.47.34 Toronto 1986.
Beppu H, 1986, Immune response to bovine serum albumin (BSA) in NOD mice: possible relevance to diabetes, Diabetes, 35, 184A
Hanafusa T, 1985, Detection of polyglandular autoantibodies in the non‐obese‐diabetic (NOD) mouse, Diabetes Res Clin Pract O, S220
Hattori M, 1986, Isolation of T lymphocyte lines from pancreatic islets of the NOD mouse, Diabetes, 35, 76A
Toyota T, 1985, Characterization of abnormalities of immune response in NOD mice as type I diabetes animal model, Diabetes Res Clin Pract O, S564
Kataoka S, 1984, Immunological aspects of the non‐obese diabetic (NOD) mouse‐(II) subpopulations of the circulating lymphocytes, Rinsho Men‐eki, 16, 681
Toyota T, 1984, Lessons from Animal Diabetes, 308
Kataoka S, 1985, Immunological aspects of the non‐obese diabetic (NOD) mouse. III. Interleukin 2 (IL‐2), and interferon (IFN), Rinsho Men‐eki, 17, 403
Toyota T, 1985, Immunological characterization of NOD mice as an animal model of type I diabetes, Rinsho Men‐eki, 17, 82
AsamotoHandAkazawaY:Immunological study of NOD mice. Annual Study Report of the Research Group for Animal Models of Incurable Diseases 1984 pp146–151.
Pontesilli O, 1986, Circulating lymphocyte populations in the nonobese diabetic (NOD) mouse, Diabetes, 35, 69A
YoshidaT NishimuraM NoseM andKyogokuN:Immunohistological analysis of the destruction of islets of Langerhans in NOD mice. Annual Study Report of the Research Group for Animal Models of Incurable Diseases 1984 pp158–159.
YoshidaTandNishimuraN:A role of Lyt 1+ 2−cells in the destruction of pancreatic islets in NOD mice. Annual Study Report of the Research Group for Animal Models of Incurable Diseases 1985.
Fujita T, 1982, Lymphocytic insulitis in a “non‐obese diabetic (NOD)” strain of mice: an immunohistochemical and electron microscope investigation, Biomed Res, 3, 429, 10.2220/biomedres.3.429
Miyazaki A, 1985, Predominance of T lymphocytes in pancreatic islets and spleen of pre‐diabetic non‐obese diabetic (NOD) mice: a longitudinal study, Clin Exp Immunol, 60, 622
Asamoto H, 1984, Infiltration of lymphocytes in various organs of the NOD (non‐obese diabetic) mouse, J Jpn Diabetes Soc, 27, 775
Motojima K, 1986, Ia+ T‐lymphocytes and Ia+ beta cells in NOD mouse islets, Diabetes, 35, 69A
HanafusaT Fujino‐KuriharaH MiyazakiA YamadaK NakajimaH MiyagawaJ KonoN NonakaK andTaruiS:Expression of class II MHC antigens on pancreatic B cells in NOD mice. Immunology of Diabetes Abstract No. S 11 Edmonton 1986.
Kolb H, 1977, Ir‐gene control of antibody class production, J Immunol, 118, 427, 10.4049/jimmunol.118.2.427
Yamada K, 1982, Preventive and therapeutic effects of large‐dose nicotinamide injections on diabetes associated with insulitis, Diabetes, 31, 749, 10.2337/diab.31.9.749
NakajimaH YamadaK Fujino‐KuriharaH HanafusaT MiyagawaJ MiyazakiA KonoN TaruiS NonakaK andTochinoY:Preventive effects of nicotinamide on spontaneously occurring diabetes in female NOD mice and cyclophosphamide‐induced diabetes in male NOD mice.Proceedings of the Second International Symposium on Treatment of Diabetes Mellitus.Excerpta Medica Amsterdam in press.
Nakajima H, 1987, Elevated antibody‐dependent T cell‐mediated cytotoxicity and its inhibition by nicotinamide in the diabetic NOD mouse, Immunol Lett, 12, 83
Yamada K, 1985, Nicotinamide prevents lymphocytic infiltration in submandibular glands but not the appearance of anti‐salivery duct antibodies in non‐obese diabetic (NOD) mice, Res Commun Chem Pathol Pharmacol, 50, 83
Nakajima H, 1985, Nicotinamide prevents the development of cyclophosphamide‐induced diabetes mellitus in male non‐obese diabetic (NOD) mice, Biomed Res, 6, 185, 10.2220/biomedres.6.185
Tanigawa K, 1985, Is immune therapy really effective in nonobese diabetic (NOD) mice?, Diabetes, 34, 175A
Nakajima H, 1985, Decreased incidence of diabetes mellitus by monosodium glutamate in the nonobese diabetic (NOD) mouse, Res Commun Chem Pathol Pharmacol, 50, 251
Kato K, 1986, Depression of delayed‐type hypersensitivity in mice with hypothalamic lesion induced by monosodium glutamate: involvement of neuroendocrine system in immunomodulation, Immunology, 58, 389